|
Cash Flow for
Infinity Pharmaceuticals Inc.
(INFI)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
(53,964) |
(40,042) |
(48,984) |
(31,279) |
23,654 |
| Depreciation |
1,643 |
2,099 |
2,184 |
2,154 |
1,972 |
| Amortization |
1,653 |
2,605 |
3,228 |
1,429 |
(1,754) |
| Amortization of Intagibles |
- |
- |
- |
- |
- |
| Deferred Income Taxes |
N/A |
N/A |
- |
- |
- |
| Operating Gains/Losses |
- |
- |
- |
(107) |
(164) |
| Extraordinary Gains/Losses |
- |
- |
- |
- |
- |
| Decrease in Receivables |
218 |
(218) |
- |
7,415 |
(2,314) |
| Decrease in Inventories |
- |
- |
- |
- |
- |
| Decrease in Prepaid Expenses |
(1,037) |
356 |
599 |
(1,075) |
74 |
| Decrease in Other Current Assets |
- |
- |
- |
- |
- |
| Increase in Payables |
- |
- |
11,762 |
(4,380) |
3,230 |
| Increase in Other Current Liabilities |
- |
- |
- |
- |
- |
| Decrease in Other Working Capital |
(38,574) |
(3,422) |
(3,649) |
13,974 |
(41,150) |
| Other Non-Cash Items |
11,579 |
8,118 |
8,274 |
7,113 |
6,029 |
| Net Cash from Continuing Operations |
(80,135) |
(33,109) |
(26,585) |
(4,757) |
(10,422) |
| Net Cash from Discontinued Operations |
- |
- |
- |
- |
- |
| Cash from Operating Activities |
(80,135) |
(33,109) |
(26,585) |
(4,757) |
(10,422) |
|
|
| Sale of Property, Plant, Equipment |
- |
- |
- |
79 |
57 |
| Sale of Long Term Investments |
- |
- |
- |
- |
- |
| Sale of Short Term Investments |
- |
138,442 |
233,523 |
161,518 |
155,185 |
| Purchase of Property, Plant, Equipment |
(1,301) |
(1,542) |
(1,949) |
(2,528) |
(1,392) |
| Acquisitions |
- |
- |
- |
- |
- |
| Purchase of Long Term Investments |
- |
- |
- |
- |
- |
| Purchase of Short Term Investments |
- |
(150,587) |
(201,095) |
(166,565) |
(172,033) |
| Other Investment Changes, Net |
- |
- |
- |
- |
- |
| Cash from Investing Activities |
(61,998) |
(13,688) |
30,480 |
(7,496) |
(18,184) |
| Cash from Discontinued Investing Activities |
- |
- |
- |
- |
- |
|
| Issuance of Debt |
- |
50,000 |
- |
- |
- |
| Issuance of Capital Stock |
293,678 |
582 |
225 |
12,032 |
21,873 |
| Repayment of Debt |
- |
(5) |
(16) |
(66) |
(414) |
| Repurchase of Capital Stock |
- |
- |
- |
- |
(8) |
| Payment of Cash Dividends |
- |
- |
- |
- |
- |
| Other Financing Charges, Net |
- |
- |
27 |
- |
565 |
| Cash from Financing Activities |
293,678 |
50,577 |
235 |
11,966 |
22,016 |
| Cash from Discontinued Financing Activities |
- |
- |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
- |
- |
- |
- |
- |
| Net Change in Cash |
151,545 |
3,780 |
4,130 |
(287) |
(6,590) |
|
| Cash at Beginning of Year |
24,197 |
20,417 |
16,287 |
16,575 |
23,165 |
| Cash at End of Period |
175,742 |
24,197 |
20,417 |
16,287 |
16,575 |
| Foreign Sales |
- |
- |
- |
- |
- |
| Domestic Sales |
- |
- |
- |
- |
- |
|
|
|
